S
MGNX icon

SignatureFD’s MacroGenics MGNX Stock Holding History

SignatureFD’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,479
Closed -$21.8K – 3205
2024
Q1 		$21.8K Hold
1,479
– – ﹤0.01% 1959
2023
Q4 		$14.2K Buy
1,479
+979
+196% +$6.77K ﹤0.01% 2093
2023
Q3 		$2.33K Sell
500
-53
-10% -$264 ﹤0.01% 2735
2023
Q2 		$2.96K Sell
553
-970
-64% -$5.98K ﹤0.01% 2678
2023
Q1 		$10.9K Buy
1,523
+1,023
+205% +$6.16K ﹤0.01% 2166
2022
Q4 		$3.35K Hold
500
– – ﹤0.01% 2629
2022
Q3 		$2K Buy
+500
New +$1.91K ﹤0.01% 2807
2022
Q2 		– Sell
-63
Closed -$1K – 3258
2022
Q1 		$1K Buy
+63
New +$695 ﹤0.01% 3023
2020
Q2 		– Sell
-430
Closed -$3K – 2602
2020
Q1 		$3K Buy
+430
New +$3.9K ﹤0.01% 1836
2019
Q3 		– Sell
-45
Closed -$1K – 2159
2019
Q2 		$1K Buy
+45
New +$773 ﹤0.01% 1909

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SignatureFD's MGNX Position: Q2 2024 in Review

SignatureFD sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 1,479 shares — an estimated $21.8K sold.

SignatureFD first reported a position in MGNX in Q2 2019 and held it in 10 quarters. The position peaked at $21.8K in Q1 2024. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • SignatureFD reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • SignatureFD sold 1,479 MacroGenics shares in Q2 2024, an estimated $21.8K.
  • SignatureFD first reported a position in MacroGenics in Q2 2019 and held it in 10 quarters.
  • SignatureFD's MacroGenics position peaked at $21.8K in Q1 2024.
  • 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on SignatureFD's 13F filing for Q2 2024, filed 29 Jul 2024.